| Title |
Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases: American Society of Clinical Oncology Clinical Practice Guideline
|
|---|---|
| Published in |
Journal of Clinical Oncology, May 2014
|
| DOI | 10.1200/jco.2013.54.0955 |
| Pubmed ID | |
| Authors |
Naren Ramakrishna, Sarah Temin, Sarat Chandarlapaty, Jennie R Crews, Nancy E Davidson, Francisco J Esteva, Sharon H Giordano, Ana M Gonzalez-Angulo, Jeffrey J Kirshner, Ian Krop, Jennifer Levinson, Shanu Modi, Debra A Patt, Edith A Perez, Jane Perlmutter, Eric P Winer, Nancy U Lin |
X Demographics
The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 18% |
| United Kingdom | 2 | 18% |
| Spain | 1 | 9% |
| Brazil | 1 | 9% |
| Germany | 1 | 9% |
| India | 1 | 9% |
| Unknown | 3 | 27% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 8 | 73% |
| Practitioners (doctors, other healthcare professionals) | 2 | 18% |
| Science communicators (journalists, bloggers, editors) | 1 | 9% |
Mendeley readers
The data shown below were compiled from readership statistics for 219 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| Canada | 1 | <1% |
| Slovenia | 1 | <1% |
| Mexico | 1 | <1% |
| Japan | 1 | <1% |
| Unknown | 214 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 43 | 20% |
| Other | 26 | 12% |
| Student > Ph. D. Student | 26 | 12% |
| Student > Master | 19 | 9% |
| Student > Postgraduate | 16 | 7% |
| Other | 43 | 20% |
| Unknown | 46 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 111 | 51% |
| Agricultural and Biological Sciences | 10 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 10 | 5% |
| Biochemistry, Genetics and Molecular Biology | 6 | 3% |
| Nursing and Health Professions | 4 | 2% |
| Other | 18 | 8% |
| Unknown | 60 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 165. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 January 2024.
All research outputs
#245,597
of 25,374,917 outputs
Outputs from Journal of Clinical Oncology
#434
of 22,047 outputs
Outputs of similar age
#1,934
of 241,898 outputs
Outputs of similar age from Journal of Clinical Oncology
#3
of 284 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,047 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.0. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 241,898 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 284 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.